Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Dartmouth-Hitchcock Medical Center
City of Hope Medical Center
Pfizer
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Baptist Health South Florida
Jonsson Comprehensive Cancer Center
Iambic Therapeutics, Inc
Sunnybrook Health Sciences Centre
Columbia University
Stanford University
Duke Street Bio Ltd
M.D. Anderson Cancer Center
Augusta University
AstraZeneca
Henry Ford Health System
Seattle Children's Hospital
Assistance Publique - Hôpitaux de Paris
University of Texas Southwestern Medical Center
UNC Lineberger Comprehensive Cancer Center
A2A Pharmaceuticals Inc.
Sunnybrook Health Sciences Centre
Baylor College of Medicine
University College, London
Jonsson Comprehensive Cancer Center
Duke University
Albert Einstein College of Medicine
Baptist Health South Florida
Columbia University
University of Utah
Plus Therapeutics
Bambino Gesù Hospital and Research Institute
University of Virginia
Second Affiliated Hospital of Guangzhou Medical University
Hospital San Carlos, Madrid